Results 41 to 50 of about 182,328 (357)

Portal Hypertensive Gastropathy: the Twilight Zone [PDF]

, 2014
As one of the major complication of liver cirrhosis, portal hypertensive gastropathy (PHG) should be an interesting topic to study. Until now the exact mechanism on how this phenomenon happened is yet, not clear.1 The occurrence of PHG is quite high in ...
Gani, R. A. (Rino)
core   +1 more source

Schistosome-induced portacaval haemodynamic changes in Rattus rattus are associated with translocation of adult worms to the lungs [PDF]

, 1998
The presence of naturally portacaval shunts has been investigated in the vasculature of normal and Schistosoma mansoni-infected Rattus rattus. Using the technique of injecting Polystyrene microspheres in the superior mesenteric vein, we demonstrated that
Coulson, P.S., Imbert-Establet, D., Mone, H., Wilson, R.A.   +3 more
core   +1 more source

Elevated Gastric Antrum Erosions in Portal Hypertension Patients: Peptic Disease or Mucosal Congestion?

The Korean Journal of Gastroenterology, 2017
Background/Aims: Portal hypertension (PH) is a syndrome characterized by chronic increase in the pressure gradient between the portal vein and inferior vena cava. Previous studies have suggested an increased frequency of antral elevated erosive gastritis
Fernanda Cordeiro de Azevedo Conejo, Mabel Tatty Medeiros Fracassi, Maurício Saab Assef, Maurício Alves Ribeiro, Luiz Arnaldo Szutan, Fabio Gonçalves Ferreira   +5 more
doaj   +1 more source

Effect of partial portal vein ligation on hepatic regeneration [PDF]

, 1988
To evaluate the effect of portal hypertension and diminished portal venous blood flow to the liver on hepatic regeneration, male rats were subjected to partial portal vein ligation and subsequently to a two-thirds partial hepatectomy.
Bollman J L, Bollum F J, Brandt J T, Bucher N LR, David H. Van Thiel, Delawir Kahn, Eagon P K, Eagon P K, Eagon P K, Fisher B, Francavilla A, Higgins E M, Hong-Shiee Lai, Kahn D, Kahn D, Kirsch R, Kizer D E, Leonard Makowka, Lowry O H, McGowan J A, Mirza Kajani, Patricia K. Eagon, Qihua Zeng, Russell D H, Starzl T E, Starzl T E, Thomas E. Starzl, Van Thiel D H, Van Thiel D H, Weinbren K   +29 more
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Association of blood cadmium levels with all-cause and cause-specific mortality among adults with non-alcoholic fatty liver disease: a prospective cohort study

Frontiers in Public Health
BackgroundCadmium (Cd) accumulates in the body over time, damaging organs such as the liver, kidneys, and brain. Some researchers have suggested that elevated blood Cd levels may contribute to the onset and progression of nonalcoholic fatty liver disease
Congxi Xu, Congxi Xu, Zhi Li, Shirui Hao, Jian Zhang, Jinlong Li, Kuopeng Liang, Xiaojuan Wang, Yi Zhang, Yi Zhang, Guangyuan Zhao, Mengyun Bai, Dengxiang Liu, Jitao Wang   +13 more
doaj   +1 more source

Effect of portal hypertension in the small bowel: an endoscopic approach [PDF]

, 2008
BACKGROUND AND AIM: The effects of portal hypertension in the small bowel are largely unknown. The aim of the study was to prospectively assess portal hypertension manifestations in the small bowel. METHODS: We compared, by performing enteroscopy with
Almeida, N, Figueiredo, P, Freitas, D, Gouveia, H, Leitão, MC, Lopes, S, Lérias, C   +6 more
core   +1 more source

The peculiarities of macroscopic status of the upper gastrointestinal tract mucosa in patients with hepatic and extrahepatic portal hypertension.

Medičnì Perspektivi, 2018
Identification of endoscopic signs of concomitant pathology of the upper gastrointestinal tract allows to determine the tactics of managing patients with different forms of portal hypertension (PG).
Yu. M. Stepanov, N. V. Chaliy, O. V. Simonova   +2 more
doaj   +1 more source

Immunogenicity and safety of a booster COVID‐19 vaccination in patients with chronic liver disease: A multicenter study

Portal Hypertension & Cirrhosis, 2023
Aim Patients with chronic liver disease (CLD), especially cirrhosis, are at a high risk of severe illness or death from coronavirus disease‐2019 (COVID‐19) and may have a suboptimal immune response to the severe acute respiratory syndrome coronavirus 2 ...
Jitao Wang, Jingwen Ai, Huiling Xiang, Yanliang Zhang, Zhiyun Hou, Qiran Zhang, Jiaojian Lv, Shubo Chen, Chuan Liu, Qianqian Li, Jing Liang, Faren Xie, Shujun Jiang, Nina Zhang, Aiguo Zhang, Xiaolin Lan, Xuying Zhang, Jinlong Li, Dengxiang Liu, Wenchuan Wang, Wei Rao, Zhang Qun, Qiuju Tian, Xiaolong Qi, Wenhong Zhang   +24 more
doaj   +1 more source

Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension [PDF]

, 2014
Cirrhosis is the final stage of most of chronic liver diseases, and is almost invariably complicated by portal hypertension, which is the most important cause of morbidity and mortality in these patients. This review will focus on the non-invasive methods
Ashkenazi, Eyal, Berzigotti, Annalisa, Bosch i Genover, Jaume, González-Abraldes Iglesias, Juan, Reverter, Enric   +4 more
core   +2 more sources